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ARTICLE
Genetic predictors of participation in optional
components of UK Biobank
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Andrew R. Wood1, George Davey Smith 2,3, Timothy M. Frayling 1 & Kate Tilling 2,3✉
Large studies such as UK Biobank are increasingly used for GWAS and Mendelian rando-
mization (MR) studies. However, selection into and dropout from studies may bias genetic
and phenotypic associations. We examine genetic factors affecting participation in four
optional components in up to 451,306 UK Biobank participants. We used GWAS to identify
genetic variants associated with participation, MR to estimate effects of phenotypes
on participation, and genetic correlations to compare participation bias across different
studies. 32 variants were associated with participation in one of the optional components
(P < 6 × 10−9), including loci with links to intelligence and Alzheimer’s disease. Genetic
correlations demonstrated that participation bias was common across studies. MR showed
that longer educational duration, older menarche and taller stature increased participation,
whilst higher levels of adiposity, dyslipidaemia, neuroticism, Alzheimer’s and schizophrenia
reduced participation. Our effect estimates can be used for sensitivity analysis to account for
selective participation biases in genetic or non-genetic analyses.
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Initial participation and continued engagement in cohort stu-dies may be influenced by an individual’s social and lifestylecharacteristics1. This selection has the potential to result in
bias in estimating phenotypic and genotypic associations2. It is
well established that large cohort studies tend to have a healthy
volunteer bias in initial participation3. There is also a growing
body of evidence suggesting that continued engagement in cohort
studies may be influenced by a range of factors. Studies have
demonstrated age, education, ancestry, geographic location and
health status are associated with loss-to-follow-up4. However, as
with all observational studies, these associations may be con-
founded and therefore not causal in nature.
In order to assess the causes of non-participation, genetic data
on a more complete sample can be leveraged. Analysis of genetic
data in the Avon Longitudinal Study of Parents and Children
(ALSPAC) demonstrated a number of factors were causally
related to participation. Education, agreeableness and openness
caused higher participation, whilst higher BMI, schizophrenia,
neuroticism and depression caused lower participation1,5. A study
in the UK Biobank6 performed a genome-wide association study
of completing the mental health questionnaire, identifying 25 loci
associated with survey completion, and strong positive genetic
correlations with educational attainment and better health and
negative genetic correlations with psychological distress and
schizophrenia.
In general, an analysis will give biased estimates if the exposure
and the outcome variable (or causes of them) are associated with
participation (conditional on the other variables in the analysis
model7). Selection bias can also occur under other circumstances
when only the outcome is related to selection, for example, if
exposure does cause the outcome, and the outcome causes
selection7. As another example, selection bias can occur if a
modifier of the effect of exposure on outcome causes selection8. A
comparison of associations between risk factors and overall and
cause-specific mortality in UK Biobank and the less-selected
Health Survey for England and Scottish Health Surveys showed
wide variation in these associations9, with some over-estimated in
UK Biobank and some under-estimated. Thus, to understand the
impact of selective participation for a particular analysis, we need
to identify factors that influence participation.
The UK Biobank has several measures of participation. Here,
we utilise up to 451,036 individuals of European ancestry in the
UK Biobank to identify factors that cause participation in the four
available optional components of the baseline study in order to
improve our understanding of the biases that may affect these
associations and lead to false inferences. The four optional
components tested were (a) the percentage of food frequency
questionnaires (FFQ) completed, (b) acceptance of the invite to
wear a physical activity monitor, (c) acceptance of an invitation to
participate in the mental health questionnaire (MHQ) and (d) the
completion of the aide-memoire. We used two-sample Mendelian
randomisation (MR) approaches to explore the role of over 80
predictors on participation in the UK Biobank. Finally, we also
explored genetic correlations between participation in the UK
Biobank and the ALSPAC study to test between study con-
sistency. If the same factors affect participation in studies that
vary by geography, time period and design, then those studies will
suffer the same bias, and thus replication of results across studies
becomes meaningless10.
This study identified 32 variants associated with participation
in at least one of the four optional components (P < 6 × 10−9),
including loci with known links to intelligence and Alzheimer’s
disease. Genetic correlations demonstrated that participation bias
was common across studies, whilst MR provided evidence that
longer educational duration, older menarche and taller stature
increased participation, whilst higher levels of adiposity,
dyslipidaemia, neuroticism, Alzheimer’s and schizophrenia
reduced participation. Our effect estimates can be used for sen-
sitivity analysis to account for selective participation biases in
genetic or non-genetic analyses.
Results
Observational associations. The demographics of the partici-
pants included in this study are summarised (Table 1). Overall,
42,429 participants completed all four optional components of
the UK Biobank study, whilst 51,141 participated in the food
frequency questionnaire (FFQ), the physical activity actigraph
monitoring and the mental health questionnaire (MHQ).
Participation in the four additional UK Biobank questionnaires
and tests was associated with older age (FFQ and aide-memoire),
female sex (all four outcomes), lower body mass index (all four
outcomes), lower levels of deprivation (all four outcomes), higher
fluid intelligence (all four outcomes), never smoking (all four
outcomes), higher self-reported physical activity using the
International Physical Activity Questionnaire (IPAQ) (FFQ and
physical activity), higher measured physical activity (aide-
memoire, MHQ), no depression (MHQ and aide-memoire) and
no type 2 diabetes (all four outcomes). There was some evidence
that the aide-memoire variable captured a different aspect of
participation, with associations in the opposite direction to the
other participation measures. For example, a longer duration in
education was associated with lower odds of completing the aide-
memoire, but higher odds of participating in the other three
components. This was further evidenced by strong observational
associations and genetic correlations between three of the
participation variables, whilst completing the aide-memoire was
not as robustly correlated with participation in the other optional
surveys (Supplementary Tables 1 and 2).
We also generated a binary variable to compare participants
who were invited to participate in at least one the optional
surveys (i.e., FFQ, MHQ and physical activity) versus those
participants not invited (Supplementary Table 3). Receiving an
invite to participate in the three optional surveys (n= 336,633)
was associated with younger age, male sex, lower body mass
index, lower levels of deprivation, higher fluid intelligence, never
smoking and a lower prevalence of type 2 diabetes.
GWAS of the participation variables identified 32 loci. GWAS
of the four participation traits was performed in individuals of
European descent using BOLT-LMM, with sample sizes of N=
300,639 for the FFQ, N= 215,127 for physical activity monitor-
ing, N= 294,787 for MHQ and N= 451,306 for aide-memoire.
After clumping and using a stringent GWAS cut-off of P < 6 ×
10−9, there were 8 loci for the FFQ, 1 locus for physical activity
participation, 21 loci for MHQ participation and 2 loci for aide-
memoire (Table 2 and Supplementary Fig. 1). Twenty-three
variants were associated at P < 6 × 10−9 with receiving an invite to
participate in any of the optional surveys (Supplementary Data 1).
All variants reaching the less stringent P < 5 × 10−8 threshold are
reported (Supplementary Tables 4 and 5). With the exception of
the aide-memoire, many of the lead variants for the other parti-
cipation measures were within 500 kb of another lead variant for
a different participation measure (Table 2 and Supplementary
Data 2). For example, 6/8 of the FFQ lead variants at P < 6 × 10−9
were within 500 kb of another lead variant for either actigraphy or
MHQ participation, whilst the only variant at P < 6 × 10−9 for
actigraphy was within 500 kb of an FFQ and MHQ variant and 4/
21 variants at P < 6 × 10−9 for the MHQ were within 500 kb of an
FFQ or actigraphy variant.
Two of the variants identified for FFQ participation were
previously identified in GWAS of intelligence (rs1121087111,12)
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and cognitive performance (rs1342859813). For both variants, the
allele associated with higher intelligence or cognitive performance
is associated with completing more FFQ. A further two variants
(rs9261655 and rs147412694) were associated with blood cell
traits14. Here, the alleles associated with higher blood cell counts
were associated with completing fewer FFQ, whilst the reason
behind this unknown, higher white blood cell counts have
previously been associated with poorer cognition15,16. Four of
the eight variants were also in high LD (r2 > 0.8) with genome-
wide significant (GWS) signals from behavioural GWAS,
including ADHD, risk tolerance, smoking and alcohol consump-
tion. As expected from previous work on participation and our
understanding of risky behaviours, alleles associated with a higher
risk of ADHD, higher-risk tolerance and a higher risk of smoking
or consuming alcohol associated with lower FFQ participation
(Table 2).
The locus identified for participation in actigraphy
(rs55714359) was in partial linkage disequilibrium with the
variants identified for participation in the mental health
questionnaire (r2= 0.52) and completing the food frequency
questionnaire (r2= 0.32). This variant was previously identified
as associated with multiple sclerosis17, with the allele associated
with higher odds of multiple sclerosis associated with lower odds
of participation in physical activity. In the UK Biobank, this
variant is also associated with adiposity related traits18. The allele
associated with higher adiposity is also associated with lower odds
of participation in physical activity monitoring.
Of the 25 loci identified in a GWAS of MHQ participation by
Adams et al.6 we replicated 15/25 (60%) at P < 6 × 10−9 and 22/25
(88%) at P < 5 × 10−8 in this larger sample of related individuals.
The three missing variants (rs35028061, rs13082026 and
rs57692580) were directionally consistent and approaching
GWS (P values were 5.1 × 10−8, 6.6 × 10−7 and 9.6 × 10−7,
respectively). Of the 21 variants associated with MHQ participa-
tion at the stringent threshold, four were previously associated
with cognitive function and intelligence measures (rs7542974,
rs485929, rs11793831 and rs710802013) and a further three were
in high LD with variants identified associated with intelligence
outcomes. For all variants, the allele associated with higher
intelligence or cognitive performance was associated with higher
odds of completing the MHQ.
A missense mutation in APOE (rs429358) was associated with
MHQ participation. The C-allele is a marker of the APOE-ε4
genotype which is a major risk factor for Alzheimer’s disease19,
and here, was associated with lower odds of participation in the
MHQ. Further analysis in the unrelated subset tested whether
individuals with APOE-ε4ε4 haplotype were less likely to
participate in the MHQ compared to those with the APOE-
ε2ε2 haplotype. Lower odds of MHQ participation was observed
in the APOE-ε4ε4 haplotype carriers 0.89 (95% CI: 0.80, 1.00) in
all individuals and in those who were less than 50 years old at
recruitment (OR: 0.81 (95% CI: 0.65, 1.00)). This suggests that
individuals with early signs of cognitive impairment had reduced
capacity to participate in the MHQ.
The variant rs58101275 has previously been associated with
bone mineral density20 and isoleucine levels21. The G allele raises
both isoleucine levels and bone mineral density (BMD) and was
associated with lower odds of completing the aide-memoire.
Previous studies have demonstrated that BMD is inversely
associated with cognition22 and Alzheimer’s disease, indicating
those with higher BMD may have a better memory.
Of the 23 variants at P < 6 × 10−9, 6 were either top signals for
MHQ participation or in high LD (r2 > 0.8) with variants for
MHQ participation (Supplementary Table 3). For all six loci, the
allele that was associated with higher odds of participation in the
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participate in at least one optional survey. Variant rs73078357
was previously identified as associated with email contact
(Supplementary Table 3). 8/23 variants were previously associated
with cognitive performance13, intelligence12 and self-reported
educational attainment13,23.
Genetic correlations with published GWAS studies. After
Bonferroni correction (P < 1.5 × 10−5), we observed strong posi-
tive genetic correlations between three of the four participation
measures (FFQ, MHQ and physical activity completion) and
qualifications, fluid intelligence, years spent in education. Strong
inverse genetic correlations were noted between three of the four
participation measures (FFQ completion, MHQ and physical
activity completion) and obesity-related traits. Completing the
aide-memoire, was strongly inversely correlated with risk-taking,
ever smoking, driving fast, having fractured bones in the last 5
years and schizophrenia. It was positively associated with suf-
fering from nerves and experiencing nervous feelings.
Genetic correlations with ALSPAC participation measures.
There were positive genetic correlations between the ALSPAC
participation measures and FFQ completion (mother: rg= 0.533,
P= 3 × 10−8; child: rg= 0.488, P= 3 × 10−9), participation in
MHQ (mother: rg= 0.616, P= 8 × 10−10, child: rg= 0.627, P=
2 × 10−12), and physical activity participation (mother rg= 0.487,
P= 2 × 10−5; child rg= 0.319, P= 0.001) (Supplementary
Table 2). The aide-memoire variable in UK Biobank was not
strongly correlated with the ALSPAC participation measures
(mother rg= 0.215, P= 0.08, child rg= 0.167, P= 0.14; Supple-
mentary Table 2). Receiving an invite to participate was strongly
correlated with the participation measures in ALSPAC (mother
rg= 0.58, P= 1 × 10−9; child rg= 0.59, P= 1 × 10−10).
Mendelian randomisation analyses. In all individuals, Mende-
lian randomisation24,25 analysis demonstrated that 27 traits
caused at least one participation measure at a threshold of
P < 0.05 (P value based on the inverse-variance weighted (IVW)
analyse, with 8 at more stringent P < 0.0001; Supplementary
Table 6). Of the 27 traits, 15, 18, 10 and 6 were associated with
FFQ, MHQ and physical activity and aide-memoire, respectively.
Longer duration in education and higher intelligence predicted
higher odds of participation in the FFQ, MHQ and physical
activity monitoring (Fig. 1A and Supplementary Table 6). For
example, a one-SD longer duration (~5 years) in education
caused higher odds of participation in the MHQ (1.78 (95% CI:
1.61, 1.98)) and physical activity monitoring (1.69 (95% CI: 1.36,
2.13)). In contrast, there was limited evidence for longer
educational duration predicting the completion of the aide-
memoire.
Higher adiposity caused lower odds of participation in the
FFQ, MHQ and physical activity monitoring. For example, the
odds ratios for participation in the MHQ and PA monitoring per
one-SD higher waist:hip ratio were 0.85 (95% CI: 0.80, 0.89) and
0.83 (95% CI: 0.75, 0.93), respectively (Fig. 1B and Supplementary
Data 3). Higher BMI caused lower odds of participation in the
FFQ and physical activity monitoring in women (Supplementary
Data 3). There was limited evidence that higher adiposity
predicted aide-memoire completion. A one-SD taller stature
caused higher odds of completing the MHQ (OR: 1.06 (95% CI:
1.04, 1.07)) and physical activity monitoring (OR: 1.07 (95% CI:
1.03, 1.11)). Taller stature also caused participants to complete
more FFQ (Fig. 1B and Supplementary Data 3). There was no
strong evidence that any of the other anthropometric measures
tested caused participation, although many of the estimates have
wide confidence intervals.
Genetic evidence demonstrated that behavioural characteristics
caused participation (Fig. 1C). For example, older age of losing
virginity caused participants to complete more FFQ and have
higher odds of participation in the MHQ (OR: 1.15 (95% CI: 1.03,
1.28)). A twofold higher genetic liability for being a morning
person chronotype caused higher odds of completing the aide-
memoire (OR: 1.02 (95% CI: 1.01, 1.04)) and lower odds of
completing the MHQ (OR: 0.98 (95% CI: 0.96, 1.00)). A twofold
higher genetic liability for riskier behaviour caused lower odds of
completing the aide-memoire (OR: 0.27 (95% CI: 0.19, 0.40)), but
was not linked to completing the optional surveys. In a subset of
former and current smokers, the role of smoking heaviness on
participation was explored. A one-SD higher cigarette per day
Fig. 1 Plots of the Mendelian Randomisation results. Dot plots representing the inverse-variance weighted results from two-sample MR analyses for
(A) educational, (B) anthropometric, (C) behavioural and (D) neurological and psychological traits. Error bars represent the 95% confidence intervals of
the IVW estimate.
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(~11 cigarettes) caused lower odds of participating in the MHQ
(OR: 0.88 (95% CI: 0.85, 0.92)) and the physical activity
monitoring (OR: 0.93 (95% CI: 0.89, 0.97)) (Supplementary
Data 4).
C-reactive protein (CRP) was the only biomarker tested with
some evidence of a causal association, with a twofold higher CRP
causing higher odds of completing the MHQ (OR: 1.08 (95% CI:
1.04, 1.12); Supplementary Data 3).
Higher genetic liability of cancer and non-cancer diseases and
poorer metabolic health generally caused lower odds of
participation (Supplementary Data 3). For example, a twofold
higher genetic liability of breast cancer was associated with lower
odds of participating in the MHQ (OR: 0.98 (95% CI: 0.96, 1.00)),
physical activity monitoring (OR: 0.97 (95% CI: 0.95, 1.00)) and
completing the aide-memoire (OR: 0.97 (95% CI: 0.95, 1.00)).
Several psychological and neurological conditions caused lower
odds of participation (Fig. 1D and Supplementary Data 4). For
example, a genetic liability to ADHD and schizophrenia was
associated with the completion of fewer FFQ and lower odds of
participation in the MHQ and physical activity monitoring. A
twofold higher genetic risk of schizophrenia lowered the odds of
completing the MHQ by 3%, (OR: 0.97 (95% CI: 0.95, 0.99)). A
genetic liability for schizophrenia also lowered the odds of
completing the aide-memoire. Genetic liability for autism and
extraversion caused fewer FFQ to be completed. Alzheimer’s
disease genetic liability was associated with lower odds of
participation in the FFQ, physical activity monitoring and
MHQ. A doubling in Alzheimer’s genetic liability was associated
with a 0.976 (95% CI: 0.969, 0.983) lower odds of completing
the MHQ.
There was little evidence that reproductive traits in women
caused participation, with the exception of age at menarche. For
example, a one year older age at menarche was associated with
1.07 (95% CI: 1.03, 1.11) and 1.07 (95% CI: 1.03, 1.12) higher
odds of completing the MHQ and physical activity monitoring,
respectively (Supplementary Data 3).
Generally, results were consistent when analysed in men and
women separately (Supplementary Data 3), with the exception of
BMI and physical activity participation, where evidence suggested
high BMI only caused lower odds of participation in women
(ORwomen: 0.88 (95% CI: 0.81, 0.96), ORmen: 1.01 (95% CI: 0.92,
1.12)), Pinteraction= 0.07).
Two-sample MR methods that are more robust to pleiotropy
generally provided similar results (Supplementary Data 3).
Discussion
This study explored the genetic basis of four different participa-
tion measures, plus whether or not participants were invited to at
least one optional element in the UK Biobank study and used
Mendelian randomisation to test the causal role of a broad range
of factors in participation.
Some individual characteristics appear to decrease the like-
lihood of participation in all of the optional invited components
of the UK Biobank study (i.e., physical activity monitoring, food
frequency and MHQ). These include lower intelligence and
educational attainment, higher adiposity and increased liability to
ADHD and neuroticism and schizophrenia. Many of these were
previously identified in the ALSPAC study1,5, previous UK Bio-
bank study analyses6 and Generation Scotland6. This implies that
missingness of all the variables collected in the optional compo-
nents of UK Biobank will be influenced by these underlying traits.
The fourth participation measure considered was the aide-
memoire, where participants were asked at baseline to complete a
short form with specific data. Our analyses suggest that this
measure captures another aspect of behaviour, perhaps reflecting
compliance rather than participation, with evidence that a genetic
liability to riskier behaviour was inversely associated with com-
pleting the aide-memoire.
GWAS identified a number of loci robustly associated with the
different participation measures. A number of genome-wide
significant loci were shared across the participation traits, sug-
gesting a general role in influencing participation. Although
further analyses using colocalization methods would be necessary
to more formally test whether these shared loci represent the
same signal. Many of the variants identified were in or near loci
which had previously been identified as associating with, intelli-
gence and cognitive function or behaviour-based traits. Alleles
associated with higher intelligence or risk aversion were con-
sistently associated with completing the MHQ and more of the
FFQ. In the MHQ GWAS, the top signal was in the highly
pleiotropic APOE locus. The allele that raises participation in the
MHQ (T) is associated with lower odds of Alzheimer’s disease19,
heart disease, inflammation and dyslipidaemia26. Further analyses
indicated that the APOE-ε4ε4 haplotype carriers were less likely
to participate in the MHQ and high genetic liability for Alzhei-
mer’s disease lowered odds of participation in the FFQ, physical
activity monitoring and the MHQ.
In addition to performing GWAS of our four participation
measures, we also performed a GWAS of invitation to participate
in at least one of the three optional components. Because only
those invited can participate, the fact that not everyone is invited
could result in collider bias in our analysis of participation27. A
factor that is positively associated with both being invited and
participation is likely to have its association with participation
biased towards the null when conditioning on having been
invited, assuming that being invited and participating are posi-
tively correlated (as demonstrated here) and that there are no
interactions (on the probability scale) between the variable and
others that also influence invitation/participation. Here, we
demonstrated that some variants were associated with higher
odds of both being invited to participate and completing the
MHQ. This suggests that here conditioning on being invited to
participate could have resulted in the Mendelian randomisation
analyses for these variables being biased towards the null, if they
were in truth positively associated with participation. However, if
there are non-linearities or interactions in the effects of the risk
factors on invitation/participation, then the direction of the bias
cannot be predicted. Similarly, a factor that affects being invited,
but does not in truth affect participation, could appear to have a
positive or negative spurious association with participation,
conditional on being invited.
Using genetic correlation analyses, we have demonstrated that
these participation issues are not specific to the UK Biobank. Two
participation measures from the ALSPAC study1 were strongly
correlated with the participation measures derived in the UK
Biobank. This fits with a previous study where strong genetic
correlations were noted between UK Biobank mental health
participation and participation in follow-up in Generation Scot-
land6. These results suggest that similar genetic factors are driving
participation in follow-up and optional components of studies,
regardless of study design, recruitment strategies and the popu-
lation demographics of the study. The similarity of factors
affecting participation across different studies is potentially
important for comparisons of results between studies—if similar
factors cause participation in different studies, then collider bias
will have the same impact on the results from each study. Thus,
results from different studies would be subject to similar biases,
causing replication of results across studies to become
meaningless.
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These results are important for informing analysis strategies
and the likely direction and magnitude of bias due to con-
ditioning only on those who participate. For the participator-only
analysis for a given model to be unbiased, it is necessary for the
outcome variable to be independent of missingness, given the
variables in the analysis model7. Thus when examining the factors
affecting physical activity, all the factors that we have shown here
to be related to participation in the physical activity monitoring
(BMI, height, education, intelligence, ADHD, age at menarche),
should be either included in the analysis model or used in other
strategies such as inverse probability weighting (IPW) or multiple
imputations (MI). Where a selection is related to the underlying
concept(s) measured by the optional component, then this con-
cept will be missing not at random and analyses where it is the
outcome will likely be biased7. On the other hand, a participator-
only analysis of a model that involves only characteristics that are
unrelated to participation will not be biased by conditioning on
participation.
Selection of the type demonstrated here may cause bias in
estimates of effects, and the size and direction of bias cannot
(usually) be exactly determined. Previous work has shown that
estimated effects of risk factors on mortality and cause-specific
mortality differ between UK Biobank and the less-selected Health
Survey for England—with some being moved towards, and some
away from the null. This could imply that selection into UK
Biobank is causing bias in estimating these effects. For example,
we have shown that smoking is negatively associated with parti-
cipation in UK Biobank. If a factor that causes lung cancer is also
negatively associated with participation (e.g., socioeconomic
position), then selecting on participating in UK Biobank would
induce a negative association between smoking and lung cancer
(assuming an additive model), which would bias the estimated
effect of smoking on lung cancer towards the null. This is indeed
what is seen in the comparison of estimates for this effect between
UK Biobank and HSE-SHS9. It should be noted that this simple
estimate of the direction of bias depends on assumptions about
the underlying selection model, and cannot be verified with only
UK Biobank data—e.g., an interaction between smoking and
socioeconomic position in their effect on participation could
change the size and direction of any bias. We have similarly
shown previously that some effect estimates were different when
calculated on only those continuing to participate in ALSPAC,
compared to all those participating at baseline1. It has also been
suggested that selection bias may (at least in part) be responsible
for overestimates of the protective effect of moderate alcohol
consumption28,29.
Strategies to investigate or minimise the impact of selection on
a given estimate depend on the data available on the population
not selected into the study. Inverse probability weighting (IPW)
has been suggested to overcome mortality bias30, but the validity
of this depends on correctly specifying the selection model. If
there is an unmeasured factor that affects selection and is related
to the variables in the analysis model, then this may mean that
inverse probability weighting is not unbiased31. IPW as a solution
also depends on having data on all the variables affecting selection
and their distribution in the population in which we wish to make
the inference. Solutions using IPW to infer bounds on estimates
have been proposed, although these can result in wide bounds, or
depend on underlying assumptions about associations of
unmeasured factors with selection32,33. Over-sampling of under-
represented subgroups of the population is used, for example in
the Millenium Cohort Study34. However, this solution will only
remove bias due to selection into those specified subgroups (not
any other selection bias). In addition, if the selection in those
subgroups now differs according to other factors—e.g., the par-
ticipators from the hard-to-reach groups are comparatively
healthier than those in the easier-to-recruit group, then new
biases may be introduced.
A key advantage to the genetic analyses presented here over the
observational analyses usually reported (and reported here in
Table 1) is the ability to draw conclusions about causality (under
the usual assumptions of MR, in particular, the assumptions
around horizontal pleiotropy). For example, smoking is related to
participation in the aide-memoire observationally (Table 1) but
may be due to confounding as there is little evidence of an
association using genetic variants associated with smoking
(Supplementary Table S8). This information about causality may
be useful to inform strategies to improve participation—for
example, if smoking caused participation then qualitative work
could be done to find out why smokers were less prone to par-
ticipate, and then to address this in recruitment/retention stra-
tegies. However, if actually the association between smoking and
participation is driven by (for example) socioeconomic position,
and had nothing to do with their actual smoking, then targeting
only smokers could be counter-productive. A strategy based only
on improving participation in smokers could even induce more
bias, in that interaction between socioeconomic position and
smoking in their effect on participation might be induced.
There are a number of limitations to this analysis. First, our
analysis sample was based on Europeans only in the UK Biobank
sample. The UK Biobank is not population-representative and
therefore these findings may not be generalisable to other
population studies. Second, email access was only available at
baseline and therefore this might not accurately reflect access to
email at the release of the various optional components. Third, it
is possible that some participants died before being able to par-
ticipate in some of the optional components, however, this
number will likely be small. Fourth, factors relating to partici-
pation may change with age. However, we saw strong genetic
correlations with our UK Biobank participation measures and the
ALSPAC measures. Fifth, the predictors used in MR, were
selected a priori and it is possible we have missed some key
predictors of participation. Finally, for MR we assume that the
genetic variants used as an instrumental variable affect the out-
come only through their effect on the exposure (i.e., the absence
of horizontal pleiotropy). Our sensitivity analyses using MR-
Egger and Median MR, which are more robust to horizontal
pleiotropy were generally consistent, although often had much
wider confidence intervals that crossed the null.
In summary, we demonstrate that genetic variants are asso-
ciated with participation in several aspects of the UK Biobank
study and that a wide range of traits cause differences in parti-
cipation. This builds on previous work in the ALSPAC study and
here we demonstrate strong genetic correlations between the UK
Biobank participation measures and ALSPAC highlighting that
these issues are likely to be seen in many studies. Our findings
highlight the potential for introducing bias into both genetic and
non-genetic analyses. All studies need to consider the importance
of selection bias and use sensitivity analyses to assess the
robustness of their conclusions.
Methods
UK Biobank. This study was conducted using the UK Biobank resource, which has
ethical approval and its own ethics committee (https://www.ukbiobank.ac.uk/
ethics/). Details of the patient and public involvement in the UK Biobank are
available online (www.ukbiobank.ac.uk/about-biobank-uk/ and https://www.
ukbiobank.ac.uk/wp-content/uploads/2011/07/Summary-EGF-consultation.pdf?
phpMyAdmin=trmKQlYdjjnQIgJ%2CfAzikMhEnx6). No patients were specifi-
cally involved in setting the research question or the outcome measures, nor were
they involved in developing plans for recruitment, design, or implementation of
this study. No patients were asked to advise on interpretation or writing up of
results. There are no specific plans to disseminate the results of the research to
study participants, but the UK Biobank disseminates key findings from projects on
its website.
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The UK Biobank study recruited over 500,000 individuals aged between 37 and
73 years (with >99.5% aged between 40 and 70 years) from across the UK between
2006 and 2010. The UK Biobank35,36 collected extensive phenotypic and genotypic
data on all participants. Here, we used data in up to 451,036 UK Biobank
individuals who were defined as European ancestry using principal component
analyses. Briefly, we generated principal components in the 100 Genomes Cohort,
using high-confidence SMPs to obtain their individual loadings. The loadings were
then used to project all of the UK Biobank samples into the same principal
component space. The individuals were then clustered using principal components
1 to 4.
Participation measures. Four participation phenotypes were derived in the UK
Biobank:
1. Percentage of food frequency questionnaires (FFQ) completed, based on the
number of invites (data field 110002, 0–4) and the number of acceptances
(data field 110001, 0–4). A binary variable was also created that represented
sent a food frequency questionnaire but never accepted (0) and sent a food
frequency questionnaire and completed at least one (1). This variable is
based on the online requests which were sent out every 3–4 months a total
of four times between February 2011 and June 2012 to participants who
provided an email address at recruitment37.
2. Participation in physical activity monitoring, a binary variable defined using
data fields 110005 and 110006. 0 represents invited but not accepted and 1
represents invited and accepted. Between February 2013 and December
2015, a random sample of participants with a valid email was invited to wear
the accelerometer. Participants from the North West region were excluded
due to participant burden concerns38.
3. Participation in a mental health questionnaire (MHQ), a binary variable
defined using data fields 20400 and 20005. 0 represents invited but not
accepted and 1 represents invited and accepted. Participants with a valid
email were invited to complete the MHQ. The UK Biobank’s contact
approach was to (a) send an initial invitation email, (b) send a reminder
email to non-responders (2 weeks after the initial invite), (c) send a
reminder to partial responders (2 weeks after they started the questionnaire)
and d) the last chance invitation after 4 months.
4. Aide-memoire completed, a binary variable derived from data field 111
which represents compliance to a request from the UK Biobank prior to
attending the assessment centre to fill out specific information to help with
the questionnaire. 0 represents non-compliance and 1 represents
compliance.
With the exception of the aide-memoire, which was requested by everyone, the
remaining variables relied on UK Biobank participants being invited to take part.
The general UK Biobank protocol was to invite everyone to participate in the
optional questionnaires and surveys, although as detailed above these invitations
were generally sent via email. To investigate the impact of this strategy, we also
created a variable to represent whether participants were invited to participate in at
least one of the optional surveys above (coded as 1) or not (coded as 0).
Genotypes. We used imputed genotypes available from the UK Biobank for
association analyses39. Variants were excluded if imputation quality (INFO) was
<0.3 or the minor allele frequency (MAF) was <0.1%. This quality control process
resulted in 6,930,712 variants for association analyses. Lead SNPs were defined as
those with the smallest P value and locus boundaries were defined using a ±0.5 Mb
distance from the lead SNP.
Observational associations. Logistic regression analyses were used to explore the
relationship between participant demographics and the four participation mea-
sures, plus the invitation measure. The Pearson correlations and overlap between
the four participation measures were also investigated. Chi-squared analyses were
used to explore the overlap of the binary participation measures.
Genome-wide association analysis. All individual variant association testing was
performed using BOLT-LMM40 v2.3. This software applies a linear mixed model
(LMM) to adjust for population structure and individual relatedness. From the
~805,000 directly-genotyped (non-imputed) variants available, we identified
524,307 good-quality variants (bi-allelic SNPs; MAF ≥ 1%; HWE P > 1 × 10−6; non-
missing in all genotype batches, total missingness <1.5% and not in a region of
long-range LD) which BOLT-LMM used to build its relatedness model. A number
of covariates (age, sex, UK Biobank assessment centre and genotyping platform
(categorical; UKBiLEVE array, UKB Axiom array interim release and UKB Axiom
array full release) were included at runtime. Here in the main paper, we only report
variants that reached a stringent P < 6 × 10−9 cut-off based on simulations41. The
results from the GWAS of receiving an invite to at least one of the three optional
surveys is also reported.
Genetic correlations. We used a method based on LD score regression42 as
implemented in the LD Hub software43, available at http://ldsc.broadinstitute.org/
ldhub/, to quantify the genetic overlap between the four participation traits and 832
traits with publicly available GWA data. This method uses the cross-products of
summary test statistics from two GWASs and regresses them against a measure of
how much variation each SNP tags (its LD score). Variants with high LD scores are
more likely to contain more true signals and thus provide a greater chance of
overlap with genuine signals between GWASs. Correlations were reported if they
reached a Bonferroni corrected P value (number of tests= 3220; P < 1.5 × 10−5).
We also used the LD score regression to explore the genetic correlation between
our participation measures and those available in the ALSPAC study1. The LD
score regression method used summary statistics from the GWAS meta-analysis of
the 4 participation measures in UK Biobank and the participation measures of
ALSPAC mother and children, calculates the cross-product of test statistics at each
SNP, and then regresses the cross-product on the LD score.
Finally, we utilised LD score regression to explore the genetic correlation
between not receiving an invite to participate in the various optional components
and the four participation measures.
Genome-wide genetic correlations do not provide evidence of causality, which
we tested with Mendelian randomisation using specific sets of variants. Instead,
they likely represent a complex mixture of direct and indirect causal associations in
both directions, pleiotropy and residual stratification. These likely properties of
genome-wide genetic correlations mean they provide a way of projecting a
phenotype measured in one study into another to test between study consistency
(e.g., the ALSPAC versus UK Biobank comparison), or, when comparing different
traits within one study, potentially a measure of correlation that is more
representative of biological processes than observational correlations, although we
note that observational correlations were usually very similar to genetic
correlations.
Mendelian randomisation. We undertook two-sample MR analyses to further test
the causal relationships between 80 exposure traits (decided a priori on the grounds
that they are common exposures and used in current MR pipelines) (Supple-
mentary Table 8) and the four different participation outcomes. The predictors
were classified into nine broad categories (Supplementary Table 4).
The two-sample MR analyses used summary-level data from the BOLT-LMM
GWAS of the participation traits. Known SNPs for each exposure trait
(Supplementary Table 4) were extracted from the GWAS results to estimate the
association of outcome and exposure-trait-SNP, whilst published coefficients from
the primary GWAS were utilised for the association of exposure with exposure-
trait-SNP. Four two-sample MR methods were performed using a custom pipeline:
inverse-variance weighting (IVW); MR-Egger24; Weighted median (WM)25;
Penalised weighted median (PWM)25. We have presented the IVW approach as
our main analysis method, with the MR-Egger, WM and PWM representing
sensitivity analyses to account for unidentified pleiotropy, which may bias our
results. Horizontal pleiotropy occurs when the genetic variants related to the
exposure of interest independently influence the outcome. IVW assumes there is
either no horizontal pleiotropy under a fixed-effect model or, if using a random-
effects model after detecting heterogeneity amongst the causal estimates, that the
strength of the association between the genetic instruments and the exposure is not
correlated with the magnitude of the pleiotropic effects (the InSIDE assumption)
and that the pleiotropic effects have an average value of zero. MR-Egger estimates
and adjusts for non-zero mean pleiotropy and therefore provides unbiased
estimates if just the InSIDE assumption holds24.
To explore the role of smoking heaviness on participation in the different
smoking strata we performed one-sample MR in the unrelated subset of Europeans
in the UK Biobank. We performed analyses in all individuals and stratified by
smoking status into never, former, current and ever smokers. Here, for our binary
participation measures, we first assessed the association between the cigarettes
per day and the smoking GRS. The predicted values and residuals from this
regression model were saved. Second, the predicted values from stage 1 were used
as the independent variable and the participation measures as the dependent
variable in a logistic regression model. As the FFQ participation measure was
continuous we utilised the ivreg2 command in Stata.
All analyses were performed in Stata version 14 or R version 3.5.0.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
This research has been conducted using the UK Biobank resource under application
number 9072. The GWAS summary statistics generated in this study have been deposited
in the GWAS catalogue (https://www.ebi.ac.uk/gwas/) under accession codes
GCST90012790, GCST90012791, GCST90012792, GCST90012793, GCST90012794. All
other data are available within the article or from the authors upon request.
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